Article Text

Download PDFPDF

THU0350 Time dependent association of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus
  1. E. Morand1,
  2. R. Kandane-Rathnayake1,
  3. W. Louthrenoo2,
  4. S.-F. Luo3,
  5. Y.-J. Wu4,
  6. A. Lateef5,
  7. V. Golder1,
  8. S. Sockalingam6,
  9. S. Navarra7,
  10. L. Zamora7,
  11. L. Hamijoyo8,
  12. Y. Katsumata9,
  13. M. Harigai9,
  14. M. Chan10,
  15. S. O’Neill11,
  16. F. Goldblatt12,
  17. C.S. Lau13,
  18. A. Hoi1,
  19. M. Nikpour14
  1. 1School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia
  2. 2Chiang Mai University Hospital, Chiang Mai, Thailand
  3. 3Chang Gung Memorial Hospital, Taipei
  4. 4Chang Gung Memorial Hospital, Keelung, Taiwan, Province of China
  5. 5National University Hospital, Singapore, Singapore
  6. 6University of Malaya, Kuala Lumpur, Malaysia
  7. 7University of Santo Tomas Hospital, Manila, Philippines
  8. 8University of Padjadjaran, Bandung, Indonesia
  9. 9Tokyo Women’s Medical University, Tokyo, Japan
  10. 10Tan Tock Seng Hospital, Tan Tong Seng, Singapore
  11. 11Liverpool Hospital, Liverpool
  12. 12Royal Adelaide Hospital and Flinders Medical Centre, Adelaide, Australia
  13. 13University of Hong Kong, Pok Fu Lam, Hong Kong
  14. 14St. Vincent’s Hospital, Melbourne, Australia


Background Lupus nephritis (LN) is a common feature of systemic lupus erythematosus (SLE). While LN is considered a contributor to irreversible organ damage in SLE, the magnitude of impact of active renal disease relative to other contributors to damage accrual is unknown.

Objectives To determine the time-dependent association of active lupus nephritis (LN) with organ damage accrual in SLE.

Methods This study was performed on patients from the Asia Pacific Lupus Collaboration (APLC) cohort. SLE Disease Activity Index-2000 (SLEDAI-2k) is collected per-visit and SLICC-ACR Damage Index (SDI) annually. Analysis was restricted to patients with ≥2 SDI scores. Active LN was defined if patients had urinary casts, proteinuria, haematuria or pyuria as indicated in the SLEDAI-2k descriptor. Organ damage accrual was defined as a change of SDI (ΔSDI>0) between baseline and final visit. Glucocorticoid (GC) categories were defined according to cumulative GC exposure at each visit as either no GC (cum.GC=0); low GC (cum.GC ≤median) or high GC (cum.GC >median). Cox regression analyses were performed.

Results 1735 patients and 5593 visits were included in the analysis. 93% of patients was female with a median ([inter-quartile range (IQR), (range)] age of 40 years.31, 51 18, 77 Median study observation period was 853 days [621, 1094].98, 1443 36% were Chinese; 20% Thai and 10% Caucasian ethnicity. 82% of patients were exposed to glucocorticoids. 40% had active renal disease at least once during the study period, and active renal disease was observed in 22% of visits (n=1238 visits). 41% of patients had organ damage at baseline and 14% accrued organ damage (272 damage accrual episodes in 250 patients). Active renal disease was significantly associated with damage accrual; after adjusting for confounders, patients with active renal disease were 66% more likely to accrue organ damage compared to those without active renal disease (adjusted hazard ratio=1.66 (95% CI: 1.26, 2.19), p-value<0.01 (table 1). High cumulative GC and age were also significantly associated with damage accrual.

Embedded Image

Conclusions Active LN is an independent risk factor for damage accrual in SLE. The concomitant independent association of GC exposure with damage accrual suggests non-GC treatments to reduce active LN are needed to reduce damage burden in SLE.

Disclosure of Interest None declared

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.